Non-alcoholic fatty liver disease

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 19 Sep 2014 English Publisher:BMJJournal:BMJ, volume 349, pages g4596-g4596 (eissn: 1756-1833,

Copyright policy )

Authors: Sattar, Naveed; Forrest, Ewan; Preiss, David;

doi: 10.1136/bmj.g4596

pmid: 25239614

pmc: PMC4168663

Non-alcoholic fatty liver disease

- Summary
- Subjects
- Metrics

Abstract

#### Summary points Non-alcoholic fatty liver disease (NAFLD) is now more common than alcoholic liver disease owing to the rapid rise in the prevalence of obesity,1 and NAFLD is the most common cause of abnormal liver function tests.2 Its prevalence worldwide is thought to be approximately 20% in the general population and up to 70% in patients with type 2 diabetes mellitus.3 The first recognisable stage of NAFLD is hepatic steatosis, when fat content exceeds 5% of liver volume. Simple steatosis is usually benign in terms of risk of progression to …

Related Organizations

NHS Greater Glasgow and Clyde
United Kingdom
University of Glasgow
United Kingdom
Glasgow Royal Infirmary
United Kingdom

Keywords

Clinical Review, Non-alcoholic Fatty Liver Disease, Risk Factors, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	288
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%